Maternal serum S100 protein in normal and down syndrome pregnancies

Prenatal Diagnosis

Volumn 19, Issue 4, 1999, Pages 334-336

  Abraha, H D ^a,b   Noble, P L ^a   Nicolaides, K H ^a   Sherwood, R A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Down syndrome; S100 protein; Trisomy 21

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; ARTICLE; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORDOCENTESIS; DOWN SYNDROME; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; KARYOTYPING; MATERNAL SERUM; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRISOMY 21;

EID: 0032916007     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199904)19:4<334::AID-PD541>3.0.CO;2-E     Document Type: Article

References (18)

1. Abraha HD, Nobel PL, Sherwood RA, Nicolaides KH. 1996. Fetal and maternal serum protein S100 in normal and trisomy 21 pregnancies (abstract). Proceedings of the XVI International Congress of Clinical Chemistry; 77.
2. Abraha HD, Fuller LC, Du Vivier AWP, Higgins EM, Sherwood RA. 1997a. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 137: 381-385.
3. Abraha HD, Butterworth RJ, Bath PMW, Wassif WS, Garthwaite J, Sherwood RA. 1997b. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 34: 366-370.
4. Aita M, Fraanze A, Gabrielli F. 1991. S100 immunoreactive interdigitating cells in normal and Down's syndrome human thymuses. Cell Biol Int Reports 15: 645-659.
5. Allore R, O'Hanlon D, Price R, Neilson K, Willard HF, Cox DR, Marks A, Dunn RJ. 1988. Gene encoding the β subunit of S100 protein in chromosome 21: implication for Down syndrome. Science 239: 1311-1313.
6. Anneren G, Esscher T, Larsson L, Olsen L, Pahlman S. 1988. S-100 protein and neurone-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus. Prenat Diagn 8: 323-328.
7. De Hann JB, Kola I. 1994. Molecular techniques used in prenatal diagnosis of Down syndrome: present and future. Clin Biochem Rev 15: 25-28.
8. Haimoto H, Hosada S, Kato K. 1987. Differential distribution of immunoreactive S100 a and S100 β proteins in normal non nervous human tissues. Lab Invest 57: 489-498.
9. Isobe T, Ishioka N, Matsuda T, Takahashi Y, Ganno S, Okuyama T. 1983. A rapid separation of S-100 subunits, by high performance liquid chromatography: the subunit composition of S-100 proteins. Biochem Int 6: 419-426.
10. Kilgman D, Hilt DC. 1988. The S100 protein family. TIBS 13: 437-443.
11. Korenberg JR, Kwashima H, Pulst SM, Ikeuchi T, Ogasawara N, Yamamoto K, Schonberg SA, West R, Allen L, Magenis E, Ikawa K, Taniguchi N, Epstein CJ. 1990. Molecular definition of a region of chromosome 21 that causes features of Down syndrome phenotype. Am J Genet 47: 236-246.
12. Marks A, Allore R. 1990. S100 protein and Down syndrome. BioEssays 12: 381-383.
13. Miller D, Tang PZ, Cartmill RSV, Griffith-Jones MD, Lilford RJ, Cuckle HS. 1992. Semi-quantitative detection of Down's syndrome with PCR. Lancet 340: 620-621.
14. Mito T, Becker LE. 1993. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome. Exper Neurol 120: 170-176.
15. Noble PL, Abraha HD, Snijders RJM, Sherwood RA, Nicolaides KH. 1996. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β-hcG and fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 6: 390-395.
16. Park JP, Wurster-Hill DH, Andrews PA, Cooley WC, Graham JM. 1987. Free proximal trisomy 21 without Down syndrome. Clin Genet 32: 342-348.
17. Weismann M, Missler U, Gottmann D, Gehring S. 1998. Plasma S-100b protein concentration in healthy adults is age-and sex-independent. Clin Chem 44: 1056-1057.
18. Zuckerman JE, Herschman HR, Levine L. 1970. Appearance of brain specific antigen (the S-100 protein) during human foetal development. J Neurochem 17: 247-251.